Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure

Journal of Heart and Lung Transplantation

Volumn 31, Issue 1, 2012, Pages 37-45

  Kato, Tomoko S ^a,b   Chokshi, Aalap ^a   Singh, Parvati ^a   Khawaja, Tuba ^a   Iwata, Shinichi ^a   Homma, Shunichi ^a   Akashi, Hirokazu ^a   Cheema, Faisal ^a   Yang, Jonathan ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Farr, Maryjane ^a   Mancini, Donna ^a   Schulze, P Christian ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

echocardiography; heart failure; remodeling; transplant; ventricular assist device

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; GELATINASE A; GELATINASE B; HYPERTENSIVE AGENT; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; NITRIC OXIDE; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART RIGHT VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; IMPLANTATION; INHALATION; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIGHT VENTRICULAR ASSIST DEVICE; RIGHT VENTRICULAR STROKE WORK INDEX; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TURNOVER TIME;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 83555164852     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.10.007     Document Type: Article

References (25)

1. E.A. Rose, A.C. Gelijns, A.J. Moskowitz Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
2. E.J. Birks, P.D. Tansley, J. Hardy Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884 (Pubitemid 44664645)
3. J.C. Matthews, T.M. Koelling, F.D. Pagani, K.D. Aaronson The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172 (Pubitemid 351713685)
4. Y. Ochiai, P.M. McCarthy, N.G. Smedira Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients Circulation 106 12 Suppl 1 2002 I198 I202
5. J.R. Fitzpatrick 3rd, J.R. Frederick, V.M. Hsu Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support J Heart Lung Transplant 27 2008 1286 1292
6. D. Westermann, D. Lindner, M. Kasner Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction Circ Heart Fail 4 2011 44 52
7. A. Biolo, M. Fisch, J. Balog Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers Circ Heart Fail 3 2010 44 50
8. D.L. Mann Mechanisms and models in heart failure: a combinatorial approach Circulation 100 1999 999 1008 (Pubitemid 29407182)
9. L. Moore, D. Fan, R. Basu, V. Kandalam, Z. Kassiri Tissue inhibitor of metalloproteinases (TIMPs) in heart failure Heart Fail Rev 2011 10.1007/s10741-011-9266-y [Epub ahead of print]
10. G. Song, G. Ouyang, Y. Mao, Y. Ming, S. Bao, T. Hu Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation J Cell Mol Med 13 2009 1706 1718
11. H. Okamoto Osteopontin and cardiovascular system Mol Cell Biochem 300 2007 1 7 (Pubitemid 46881810)
12. J.W. Cooper, N.C. Nanda, E.F. Philpot, P. Fan Evaluation of valvular regurgitation by color Doppler J Am Soc Echocardiogr 2 1989 56 66
13. S. Puwanant, K.K. Hamilton, C.T. Klodell Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation J Heart Lung Transplant 27 2008 1102 1107
14. M. Kukucka, A. Stepanenko, E. Potapov Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices J Heart Lung Transplant 30 2011 64 69
15. E.V. Potapov, A. Stepanenko, M. Dandel Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device J Heart Lung Transplant 27 2008 1275 1281
16. D. Saeed, T. Kidambi, S. Shalli Tricuspid valve repair with left ventricular assist device implantation: Is it warranted? J Heart Lung Transplant 30 2011 530 535
17. A.S. Maisel, P. Krishnaswamy, R.M. Nowak Breathing Not Properly Multinational Study Investigators Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167 (Pubitemid 34764819)
18. W.L. Holman, R.L. Kormos, D.C. Naftel Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study J Heart Lung Transplant 28 2009 44 50
19. Y. Sakata, K. Yamamoto, T. Mano Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor Circulation 109 2004 2143 2149 (Pubitemid 38620225)
20. P. Francia, C. Balla, A. Ricotta et al. Plasma osteopontin reveals left ventricular reverse remodeling following cardiac resynchronization therapy in heart failure Int J Cardiol 2010 10.1016/j.ijcard.2010.08.048 [Epub ahead of print]
21. K. Klingel, R. Kandolf Osteopontin: a biomarker to predict the outcome of inflammatory heart disease Semin Thromb Hemost 36 2010 195 202
22. N.A. Trueblood, Z. Xie, C. Communal Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin Circ Res 88 2001 1080 1087 (Pubitemid 34137122)
23. J.M. Lorenzen, N. Nickel, R. Krmer, H. Golpon Osteopontin in patients with idiopathic pulmonary hypertension Chest 139 2011 1010 1017
24. H. Milting, P. Ellinghaus, M. Seewald Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices J Heart Lung Transplant 27 2008 589 596 (Pubitemid 351715387)
25. T.S. Kato, A. Chokshi, P. Singh Effects of continuous- versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling Circ Heart Fail 4 2011 546 553